A preclinical study conducted by a group of researchers at the University of Pennsylvania shows promise in treating cystic fibrosis using RNA therapeutics.

Advancements in RNA therapeutic delivery are extending beyond liver-specific treatments, addressing complex challenges and enabling broader applications in medicine. Innovations in lipid nanoparticles, RNA interference, and artificial intelligence are key to this progress, offering potential treatments for a range of diseases and moving closer to personalized medicine. Despite remaining challenges, these developments mark significant strides towards transformative patient care.

From weeks to minutes with Omics Playground

Industry-leading Microfluidizer® processor technology for optimum performance and superior product quality.

Karikó's efforts and dedication have had a profound impact on the world, allowing us to navigate the pandemic with the help of mRNA vaccines.

Product Highlight

From weeks to minutes with Omics Playground

Industry-leading Microfluidizer® processor technology for optimum performance and superior product quality

What needs to be considered for RNA drug delivery? From the stability of LNPs, to proteins in the blood, to descant selection and packaging.

Where is the formulation and delivery of mRNA vaccines heading in the years after the pandemic?

RNA therapeutics have great potential, as evidenced by the success of Pfizer-BioNTech and Moderna’s COVID vaccines. One difficulty that may stunt their success lies in their delivery challenges.